{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T05:33:51Z","timestamp":1793424831111,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012415","name":"Biomedical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012415","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006510","name":"Duke University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006510","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Retina"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.oret.2019.06.002","type":"journal-article","created":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T00:20:51Z","timestamp":1560298851000},"page":"1045-1055","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"title":["The Evolution of Fibrosis and Atrophy and Their Relationship with Visual Outcomes in Asian Persons with Neovascular Age-Related Macular Degeneration"],"prefix":"10.1016","volume":"3","author":[{"given":"Chui Ming Gemmy","family":"Cheung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilraj S.","family":"Grewal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelvin Yi Chong","family":"Teo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditi","family":"Mohla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usha","family":"Chakravarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tien Yin","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn J.","family":"Jaffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.oret.2019.06.002_bib1","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/S0140-6736(12)60282-7","article-title":"Age-related macular degeneration","volume":"379","author":"Lim","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.oret.2019.06.002_bib2","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","article-title":"Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis","volume":"2","author":"Wong","year":"2014","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.oret.2019.06.002_bib3","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.ophtha.2009.10.007","article-title":"The prevalence of age-related macular degeneration in Asians: a systematic review and meta-analysis","volume":"117","author":"Kawasaki","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2019.06.002_bib4","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa054481","article-title":"Ranibizumab for neovascular age-related macular degeneration","volume":"355","author":"Rosenfeld","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.oret.2019.06.002_bib5","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.ophtha.2012.03.053","article-title":"Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results","volume":"119","author":"Martin","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2019.06.002_bib6","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.ophtha.2013.01.014","article-title":"Genetic influences on the outcome of anti-vascular endothelial growth factor treatment in neovascular age-related macular degeneration","volume":"120","author":"Abedi","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2019.06.002_bib7","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/IAE.0000000000000466","article-title":"Pharmacogenomics of response to anti-VEGF therapy in exudative age-related macular degeneration","volume":"35","author":"Dedania","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.oret.2019.06.002_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.survophthal.2013.03.009","article-title":"Predictors of anti-VEGF treatment response in neovascular age-related macular degeneration","volume":"59","author":"Finger","year":"2014","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.oret.2019.06.002_bib9","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.ophtha.2014.11.017","article-title":"Pigment epithelial detachment followed by retinal cystoid degeneration leads to vision loss in treatment of neovascular age-related macular degeneration","volume":"122","author":"Schmidt-Erfurth","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2019.06.002_bib10","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1007\/s00417-012-1928-5","article-title":"Relationship between retinal morphological findings and visual function in age-related macular degeneration","volume":"250","author":"Akagi-Kurashige","year":"2012","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.oret.2019.06.002_bib11","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1016\/j.ophtha.2013.01.073","article-title":"Macular morphology and visual acuity in the Comparison of Age-Related Macular Degeneration Treatments Trials","volume":"120","author":"Jaffe","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2019.06.002_bib12","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ophtha.2018.08.035","article-title":"Macular morphology and visual acuity in year five of the Comparison of Age-Related Macular Degeneration Treatments Trials","volume":"126","author":"Jaffe","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2019.06.002_bib13","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.ophtha.2013.12.029","article-title":"Morphologic parameters relevant for visual outcome during anti-angiogenic therapy of neovascular age-related macular degeneration","volume":"121","author":"Simader","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2019.06.002_bib14","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ophtha.2015.09.013","article-title":"Predictive value of retinal morphology for visual acuity outcomes of different ranibizumab treatment regimens for neovascular AMD","volume":"123","author":"Waldstein","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2019.06.002_bib15","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1001\/jamaophthalmol.2014.1019","article-title":"Sustained visual acuity loss in the Comparison of Age-Related Macular Degeneration Treatments Trials","volume":"132","author":"Ying","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.oret.2019.06.002_bib16","article-title":"Changes in neovascular lesion hyperreflectivity after anti-VEGF treatment in age-related macular degeneration: an integrated multimodal imaging analysis","volume":"57","author":"Casalino","year":"2016","journal-title":"Invest Opthalmol Vis Sci"},{"key":"10.1016\/j.oret.2019.06.002_bib17","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/j.ophtha.2015.05.042","article-title":"Subretinal hyperreflective material in the Comparison of Age-Related Macular Degeneration Treatments Trials","volume":"122","author":"Willoughby","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2019.06.002_bib18","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.ophtha.2013.10.019","article-title":"Risk of scar in the Comparison of Age-Related Macular Degeneration Treatments Trials","volume":"121","author":"Daniel","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2019.06.002_bib19","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.survophthal.2017.01.008","article-title":"Retinal angiomatous proliferation","volume":"62","author":"Tsai","year":"2017","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.oret.2019.06.002_bib20","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.preteyeres.2016.04.002","article-title":"Age-related macular degeneration and polypoidal choroidal vasculopathy in Asians","volume":"53","author":"Wong","year":"2016","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.oret.2019.06.002_bib21","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.oret.2018.11.003","article-title":"A\u00a0multi-country comparison of real world management and outcomes of polypoidal choroidal vasculopathy\u2014Fight Retinal Blindness! cohort","volume":"3","author":"Teo","year":"2019","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.oret.2019.06.002_bib22","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1097\/IAE.0000000000000255","article-title":"Understanding indocyanine green angiography in polypoidal choroidal vasculopathy","volume":"34","author":"Cheung","year":"2014","journal-title":"Retina"},{"key":"10.1016\/j.oret.2019.06.002_bib23","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.ophtha.2017.11.019","article-title":"Polypoidal choroidal vasculopathy","volume":"125","author":"Cheung","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2019.06.002_bib24","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1097\/IAE.0b013e31824f91e8","article-title":"EVEREST study","volume":"32","author":"Koh","year":"2012","journal-title":"Retina"},{"key":"10.1016\/j.oret.2019.06.002_bib25","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.preteyeres.2016.04.002","article-title":"Age-related macular degeneration and polypoidal choroidal vasculopathy in Asians","volume":"53","author":"Wong","year":"2016","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.oret.2019.06.002_bib26","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/j.1442-9071.2012.02765.x","article-title":"Asian age-related macular degeneration phenotyping study: rationale, design and protocol of a prospective cohort study","volume":"40","author":"Cheung","year":"2012","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.oret.2019.06.002_bib27","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00417-012-2029-1","article-title":"Six-month visual prognosis in eyes with submacular hemorrhage secondary to age-related macular degeneration or polypoidal choroidal vasculopathy","volume":"251","author":"Cheung","year":"2012","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.oret.2019.06.002_bib28","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.oret.2018.06.014","article-title":"Association between choroidal thickness and drusen subtypes in age-related macular degeneration","volume":"2","author":"Cheung","year":"2018","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.oret.2019.06.002_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/srep41386","article-title":"Systemic, ocular and genetic risk factors for age-related macular degeneration and polypoidal choroidal vasculopathy in Singaporeans","volume":"7","author":"Cheung","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.oret.2019.06.002_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101057","article-title":"A\u00a0prospective study of treatment patterns and 1-year outcome of Asian age-related macular degeneration and polypoidal choroidal vasculopathy","volume":"9","author":"Cheung","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.oret.2019.06.002_bib31","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ajo.2014.05.004","article-title":"Comparison of exudative age-related macular degeneration subtypes in Japanese and French patients: multicenter diagnosis with multimodal imaging","volume":"158","author":"Coscas","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2019.06.002_bib32","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ophtha.2016.12.002","article-title":"Imaging protocols in clinical studies in advanced age-related macular degeneration: recommendations from classification of atrophy consensus meetings","volume":"124","author":"Holz","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2019.06.002_bib33","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1097\/IAE.0000000000000499","article-title":"Three-year results of polypoidal choroidal vasculopathy treated with photodynamic therapy","volume":"35","author":"Wong","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.oret.2019.06.002_bib34","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ophtha.2013.08.015","article-title":"Risk of geographic atrophy in the comparison of age-related macular degeneration treatments trials","volume":"121","author":"Grunwald","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2019.06.002_bib35","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/IAE.0000000000000374","article-title":"Geographic atrophy in patients receiving anti-vascular endothelial growth factor for neovascular age-related macular degeneration","volume":"35","author":"Xu","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.oret.2019.06.002_bib36","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ophtha.2018.07.013","article-title":"Intralesional macular atrophy in anti-vascular endothelial growth factor therapy for age-related macular degeneration in the IVAN trial","volume":"126","author":"Bailey","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2019.06.002_bib37","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/S0140-6736(13)61501-9","article-title":"Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial","volume":"382","author":"Chakravarthy","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.oret.2019.06.002_bib38","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.ophtha.2012.04.015","article-title":"Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration","volume":"119","author":"Chakravarthy","year":"2012","journal-title":"Ophthalmology"}],"container-title":["Ophthalmology Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653019300296?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653019300296?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:26:33Z","timestamp":1762853193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468653019300296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":38,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S2468653019300296"],"URL":"https:\/\/doi.org\/10.1016\/j.oret.2019.06.002","relation":{},"ISSN":["2468-6530"],"issn-type":[{"value":"2468-6530","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Evolution of Fibrosis and Atrophy and Their Relationship with Visual Outcomes in Asian Persons with Neovascular Age-Related Macular Degeneration","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Retina","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oret.2019.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}